There are 2934 resources available
Immunotherapy 101
Presenter: Christian Blank
Session: Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients?
Resources:
Slides
Webcast
Case study: NSCLC
Presenter: Miklos Pless
Session: Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients?
Resources:
Slides
Webcast
Innovative Medicines Initiative: Calling for research on immunotherapies?
Presenter: Kjetil Tasken
Session: Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients?
Resources:
Slides
Webcast
Patient perspective
Presenter: Bettina Ryll
Session: Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients?
Resources:
Slides
Webcast
EONS - Translating the YCN survey results into clinical practice: What is the way forward?
Presenter: Sara Parreira
Session: EONS 12: Collaborative session EONS YCN - ESMO YOC: Addressing the needs of young cancer professionals
Resources:
Slides
Webcast
Personalised oncogenomics: Is a precision approach necessary for every cancer or is there a therapy-driven bottleneck?
Presenter: David Huntsman
Session: Molecular tumour board: Where do we stand? What’s next?
Resources:
Slides
Webcast
Building of a comprehensive clinical and molecular genomics database for patients with treatment-refractory cancers enrolled in clinical trials
Presenter: Philippe Bedard
Session: Molecular tumour board: Where do we stand? What’s next?
Resources:
Slides
Webcast
Tissue and liquid biopsies with MTB for phase 1 trial selection: Experience in the TARGET trial
Presenter: Matthew Krebs
Session: Molecular tumour board: Where do we stand? What’s next?
Resources:
Slides
Webcast
Setting up genomic tumour boards: What can be done and what needs to be done?
Presenter: Scott Tomlins
Session: Genomic tumour boards to deliver better prostate cancer care
Resources:
Slides
Webcast
Cancer stem cells: Are they a valid therapeutic target?
Presenter: Simone Niclou
Session: Glioblastoma treatment: Where should the future lead?
Resources:
Slides
Webcast